Atypical ductal hyperplasia: Our experience in the management and long term clinical follow-up in 71 patients.

[1]  Kenny Q. Ye,et al.  Correction to: Association between lifestyle, menstrual/reproductive history, and histological factors and risk of breast cancer in women biopsied for benign breast disease , 2018, Breast Cancer Research and Treatment.

[2]  Tejas Mehta,et al.  Surgical upgrade rate of breast atypia to malignancy: An academic center's experience and validation of a predictive model , 2018, The breast journal.

[3]  David V Schacht,et al.  Value of breast MRI for patients with a biopsy showing atypical ductal hyperplasia (ADH) , 2017, Journal of magnetic resonance imaging : JMRI.

[4]  A. Degnim,et al.  Flat Epithelial Atypia on Core Biopsy and Upgrade to Cancer: a Systematic Review and Meta-Analysis , 2017, Annals of Surgical Oncology.

[5]  A. Degnim,et al.  Lobular Neoplasia and Atypical Ductal Hyperplasia on Core Biopsy: Current Surgical Management Recommendations , 2017, Annals of Surgical Oncology.

[6]  Barbara L. Smith,et al.  Reassessing risk models for atypical hyperplasia: age may not matter , 2017, Breast Cancer Research and Treatment.

[7]  Robert T. Fazzio,et al.  Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia , 2017, Breast Cancer Research and Treatment.

[8]  Jane M Lange,et al.  Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy , 2017, JAMA oncology.

[9]  C. Zuiani,et al.  Management of atypical lobular hyperplasia, atypical ductal hyperplasia, and lobular carcinoma in situ , 2016, Expert review of anticancer therapy.

[10]  A. Renshaw,et al.  Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies. , 2016, Pathology.

[11]  G. Colditz,et al.  Breast cancer risk associated with benign breast disease: systematic review and meta-analysis , 2015, Breast Cancer Research and Treatment.

[12]  Derek C. Radisky,et al.  Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study , 2014, Cancer Prevention Research.

[13]  M. Mathieu,et al.  A Model to Predict the Risk of Upgrade to Malignancy at Surgery in Atypical Breast Lesions Discovered on Percutaneous Biopsy Specimens , 2013, Annals of Surgical Oncology.

[14]  C. Zuiani,et al.  High-risk breast lesions at imaging-guided needle biopsy: usefulness of MRI for treatment decision. , 2012, AJR. American journal of roentgenology.

[15]  B. Pockaj,et al.  Atypical Ductal Hyperplasia on Core Biopsy: An Automatic Trigger for Excisional Biopsy? , 2012, Annals of Surgical Oncology.

[16]  M J Goldacre,et al.  Benign breast disease and subsequent breast cancer: English record linkage studies. , 2010, Journal of public health.

[17]  N. Khouri,et al.  Incidental Minimal Atypical Lobular Hyperplasia on Core Needle Biopsy: Correlation With Findings on Follow-up Excision , 2010, The American journal of surgical pathology.

[18]  J. Simpson.  Update on atypical epithelial hyperplasia and ductal carcinoma in situ. , 2009, Pathology.

[19]  C. Zuiani,et al.  Borderline breast lesions diagnosed at core needle biopsy: can magnetic resonance mammography rule out associated malignancy? Preliminary results based on 79 surgically excised lesions. , 2008, Breast.

[20]  T. Rohan,et al.  Benign proliferative epithelial disorders of the breast: a review of the epidemiologic evidence , 2008, Breast Cancer Research and Treatment.

[21]  R. Vierkant,et al.  Stratification of breast cancer risk in women with atypia: a Mayo cohort study. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  Judith Abrams,et al.  Breast Cancer Incidence in a Cohort of Women with Benign Breast Disease from a Multiethnic, Primary Health Care Population , 2007, The breast journal.

[23]  R. Poppiti,et al.  Should the Extent of Lobular Neoplasia on Core Biopsy Influence the Decision for Excision? , 2007, The breast journal.

[24]  W. Berg.  Image-guided breast biopsy and management of high-risk lesions. , 2004, Radiologic clinics of North America.

[25]  W. Dupont,et al.  Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study , 2003, The Lancet.

[26]  D. Ikeda,et al.  Atypical ductal hyperplasia: can some lesions be defined as probably benign after stereotactic 11-gauge vacuum-assisted biopsy, eliminating the recommendation for surgical excision? , 2002, Radiology.

[27]  C. Lee,et al.  Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. , 2000, Radiology.

[28]  J. Andersen,et al.  Lobular carcinoma in situ. A long-term follow-up in 52 cases. , 2009 .